Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
- (-) Isotope Science and Enrichment Directorate (6)
Researcher
- Mike Zach
- Mingyan Li
- Sam Hollifield
- Andrew F May
- Ben Garrison
- Brad Johnson
- Brian Weber
- Bruce Moyer
- Charlie Cook
- Christopher Hershey
- Craig Blue
- Daniel Rasmussen
- Debangshu Mukherjee
- Debjani Pal
- Hsin Wang
- Isaac Sikkema
- James Klett
- Jeffrey Einkauf
- Jennifer M Pyles
- John Lindahl
- Joseph Olatt
- Justin Griswold
- Kevin Spakes
- Kunal Mondal
- Kuntal De
- Laetitia H Delmau
- Lilian V Swann
- Luke Koch
- Luke Sadergaski
- Mahim Mathur
- Mary A Adkisson
- Md Inzamam Ul Haque
- Nedim Cinbiz
- Olga S Ovchinnikova
- Oscar Martinez
- Padhraic L Mulligan
- Sandra Davern
- T Oesch
- Tony Beard

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

The technologies provide a system and method of needling of veiled AS4 fabric tape.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

ORNL will develop an advanced high-performing RTG using a novel radioisotope heat source.

Real-time tracking and monitoring of radioactive/nuclear materials during transportation is a critical need to ensure safety and security. Current technologies rely on simple tagging, using sensors attached to transport containers, but they have limitations.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

This innovative approach combines optical and spectral imaging data via machine learning to accurately predict cancer labels directly from tissue images.